Is Bicara Therapeutics Inc. Common Stock (BCAX) a Buy, Sell, or Hold?
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$28.1 USD
-$0.05 (-0.18%)
- Volume
- 0
- Average Volume
- 690.69K
- Market Capitalization
- $1.54B
- P/E Ratio
- -10.11
- Dividend Yield
- 0.00%
- Price Target
- $37.00
- Year High
- $30.99
- Year Low
- $9.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.85
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-24.1% DOWNSIDE
$37.00 Price Target
UPSIDE/DOWNSIDE HIGH
-33.1% DOWNSIDE
$42.00 Price Target High
UPSIDE/DOWNSIDE LOW
56.1% UPSIDE
$18.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Richard Law | $14 | $14.8 | 2026-02-11 04:42 PM | -5.4% |
| Mizuho Securities | Joseph Catanzaro | $18 | $17.98 | 2025-12-17 04:10 PM | 0.1% |
| H.C. Wainwright | Robert Burns | $40 | $11.84 | 2025-08-22 06:44 AM | 237.8% |
| Wells Fargo | Eva Fortea Verdejo | $8 | $9.27 | 2025-05-23 12:54 PM | -13.7% |
| Morgan Stanley | Judah Frommer | $35 | $24.45 | 2024-10-08 01:56 AM | 43.1% |